Type-specific persistence of high-risk human papillomavirus infections in the new independent states of the former Soviet Union cohort study

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 1, 2007, Pages 17-22

  Kulmala, Satu Maria A ^a   Shabalova, Irena P ^b   Petrovitchev, Nikolay ^b   Syrjänen, Kari J ^c   Gyllensten, Ulf B ^d   Johansson, Bo C ^e   Syrjänen, Stina M ^a   Kozachenko, V ^f   Podistov, J ^f   Ivanchenko, O ^f   Zakharenko, S ^f   Nerovjna, R ^f   Kljukina, L ^f   Branovskaja, M ^f   Grunberga, V ^f   Juschenko, A ^f   Zakharova, T ^f   Pajanidi, J ^f   Chemeris, G ^f   Sozaeva, L ^f   Lipova, E ^f   Tsidaeva, I ^f   Pshepurko, A ^f   Erokhina, O ^f   Nikitina, M ^f   Grunberg, A ^f   Cintorino, M ^f   Santopietro, R ^f   Tosi, P ^f   more..

^a UNIVERSITY OF TURKU   (Finland)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d UPPSALA UNIVERSITY   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN TISSUE; MAJOR CLINICAL STUDY; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; USSR; VIRUS DNA CELL DNA INTERACTION; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; USSR; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 33846586716     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0649     Document Type: Article

References (27)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
2. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
3. Nobbenhuis M, Helmerhorst T, van den Brule A, et al. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 2001;358:1782-3.
4. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180:1415-23.
5. Syrjänen S, Shabalova I, Petrovichev N, et al. Clearance of high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study). Eur J Obstet Gynecol Reprod Biol 2005;119:219-27.
6. Kjaer S, van den Brule A, Paull G, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002;325:572.
7. Ylitalo N, Josefsson A, Melbye M, et al. A prospective study showing long-term infection with human papillomavirus 16 before the development on cervical carcinoma in situ. Cancer Res 2000;60:6062-32.
8. Syrjänen S, Shabalova I, Petrovichev N, et al. Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet Union. Eur J Gynaecol Oncol 2005b;26:491-8.
9. Richardson H, Kelsall G, Tellier P, et al. The natural history, of type-specific human papillomavirus infection in female university students. Cancer Epidemiol Biomarkers Prev 2003;12:485-90.
10. Liaw KL, Hildeshaeim A, Burk RD, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001;183:8-15.
11. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
12. Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
13. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001;184:1508-17.
14. Dalstein V, Rietmuller D, Pretet JL, et al. Persistence and load of high-risk HPV are predictors for development of high- grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003;106:396-403.
15. van Duin M, Snijders PJ, Schrijnemakers HF, et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 2002;98:590-5.
16. Syrjänen S, Shabalova I, Petrovichev N, et al. Human papillomavirus testing and conventional pap smear cytology as optional screening tools of women at different risks for cervical cancer in the countries of the former Soviet Union. J Lower Genital Tract Dis 2002;6:97-110.
17. Syrjänen S, Shabalova I, Petrovichev N, et al. Sexual habits and human papillomavirus (HPV) infections among women in three New Independent States of the former Soviet Union. Sex Transm Dis 2003;30:680-4.
18. Kulmala SM, Syrjänen S, Shabalova I, et al. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol 2004;42:2470-5.
19. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
20. Syrjänen S, Shabalova I, Petrovichev N, et al. Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the former Soviet Union. J Clin Microbiol 2004;42:505-11.
21. Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003;41:3221-8.
22. Peitsaro P, Johansson B, Syrjänen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002;40:886-91.
23. Kulmala SM, Syrjänen SM, Gyllensten U, et al. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 2006;59:513-7.
24. Xi LF, Demers GW, Koutsky LA, et al. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 1995;172:747-55.
25. Kurvinen K, Yliskoski M, Saarikoski S, Syrjänen K, Syrjänen S. Variants of the long control region of human papillomavirus type 16. Eur J Cancer 2000;36:1402-10.
26. Giuliano A, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the young women's health study. J Infect Dis 2002;186:462-9.
27. Kalantari M, Karlsen F, Kristensen G, Holm R, Hagmar B, Johansson B. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 1998;17:146-53.